As part of a clinical trial of the effect of Efamol on primary Sjögren's Syndrome (SS), 36 patients were interviewed about nasal symptoms and examined for sense of smell and nasal mucociliary clearance. The sense of smell was examined by quantitative olfactometry using coffee as a stimulant while mucociliary clearance was evaluated by the saccharin test. The findings were compared with those of an age and sex matched control group. 39% of the patients complained of dryness of the nose and 44% of nasal crust formation whereas none of the healthy controls had such complaints. In contrast no differences in sense of smell (subjectively as well as objectively) and mucociliary clearance could be demonstrated. Neither was there any correlation between mucociliary clearance and crust formation or dryness of the nose. Also the mucociliary clearance was not correlated to the "break up time" of the tear-film determined by the ophthalmologist. The present findings indicate that examination of the sense of smell and nasal mucociliary clearance is of little diagnostic value in primary SS and cannot be used for monitoration of disease activity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mucociliary clearance
24
sense smell
16
smell nasal
12
primary sjögren's
8
sjögren's syndrome
8
nasal mucociliary
8
dryness nose
8
crust formation
8
mucociliary
6
clearance
6

Similar Publications

Innate immune function in chronic rhinosinusitis.

J Allergy Clin Immunol

January 2025

Division of Rhinology, Department of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine; Monell Chemical Senses Center, Philadelphia; PA; Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA. Electronic address:

View Article and Find Full Text PDF

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.

Adv Biotechnol (Singap)

January 2025

National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

The co-circulation of influenza and SARS-CoV-2 has led to co-infection events, primarily affecting children and older adults, who are at higher risk for severe disease. Although co-infection prevalence is relatively low, it is associated with worse outcomes compared to mono-infections. Previous studies have shown that the outcomes of co-infection depend on multiple factors, including viral interference, virus-host interaction and host response.

View Article and Find Full Text PDF

Objective: Cystic fibrosis (CF) is a clinical entity defined by aberrant chloride (Cl) ion transport causing downstream effects on mucociliary clearance (MCC) in sinonasal epithelia. Inducible deficiencies in transepithelial Cl transport via CF transmembrane conductance regulator (CFTR) has been theorized to be a driving process in recalcitrant chronic rhinosinusitis (CRS) in patients without CF. We have previously identified that brief exposures to bacterial lipopolysaccharide (LPS) in mammalian cells induces an acquired dysfunction of CFTR in vitro and in vivo.

View Article and Find Full Text PDF

Recently, there has been growing interest in knowing the best hygrometry level during high-flow nasal oxygen and non-invasive ventilation (NIV) and its potential influence on the outcome. Various studies have shown that breathing cold and dry air results in excessive water loss by nasal mucosa, reduced mucociliary clearance, increased airway resistance, reduced epithelial cell function, increased inflammation, sloughing of tracheal epithelium, and submucosal inflammation. With the Coronavirus Disease 2019 pandemic, using high-flow nasal oxygen with a heated humidifier has become an emerging form of non-invasive support among clinicians.

View Article and Find Full Text PDF

Introduction: Incidences of infections with Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) are still high and treatment guidelines lack specific recommendations for outpatients with Coronavirus-induced disease 2019 (COVID-19). Phytomedicine ELOM-080, an enhancer of mucociliary clearance (MCC), showed benefits as add-on therapy in hospitalised COVID-19 patients.

Methods: This randomised, double-blind, placebo-controlled proof-of-concept study investigated whether outpatients with mild to moderate acute symptomatic COVID-19 would benefit from a 14-day treatment with ELOM-080 with regard to potential early treatment effects on cough and further typical COVID-19 symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!